Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2015

Open Access 01-12-2015 | Study protocol

Evaluation of a hospital-based day-structuring exercise programme on exacerbated behavioural and psychological symptoms in dementia - the exercise carrousel: study protocol for a randomised controlled trial

Authors: Tim Fleiner, Wiebren Zijlstra, Hannah Dauth, Peter Haussermann

Published in: Trials | Issue 1/2015

Login to get access

Abstract

Background

Conceptual reviews and observational studies describe a link between physical inactivity and behavioural disturbances in people with dementia. Consequently, treatment of these symptoms requires physical activation and pharmacological or physical immobilization should be avoided. The few trials that have been conducted in inpatient dementia care to investigate the effects of exercise on behavioural and psychological symptoms revealed inconsistent results. Due to a lack of evidence, there is a paucity of recommendations for physical activation in this stage of care. Therefore, this trial seeks to investigate the effects of a day-structuring exercise programme on behavioural and psychological symptoms as well as on circadian rhythms of patients with dementia, hospitalized because of their behavioural and psychological disturbances.

Methods/Design

A single-centre randomised controlled trial will be conducted in three special dementia care units of an old age psychiatry hospital. Enrolled patients will receive either a 2-week exercise programme, or a 2-week social stimulation programme in addition to usual care. Due to the provision of four day-structuring exercise-sessions in the course of an intervention day, the exercise programme for the study group is called exercise-carrousel. Baseline and post-intervention assessment for the primary outcome variable - the overall effects on behavioural and psychological symptoms - will be measured by the Alzheimer's disease Cooperative Study-Clinical Global Impression of Change. The following objectives are set up as secondary outcomes: dimensions of the behavioural and psychological symptoms of dementia (BPSD) and caregiver burden, routine and on-demand psychotropic medication, patients’ motor behaviour, diurnal cortisol-levels from saliva probes and brain-derived neurotrophic factor-levels from blood serum.

Discussion

In order to be regarded as an important treatment option for behavioural and psychological symptoms, physical activation in inpatient hospital dementia care requires more evidence and appropriate recommendations. Respecting hospital routines and the intra-daily variability of the patients’ motivation and behavioural disturbances in the provision of exercise sessions could lead to higher exercise adherence and better effects on patients’ behavioural and psychological symptoms than former trials have presented. The concealment of allocation throughout the trial and the rating of individual exercise exertion present the key challenges and main limitations of this trial.

Trial registration

DRKS00006740 (German Clinical Trial Register, date of registration: 28 October 2014).
Literature
1.
2.
Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, et al. Neuropsychiatric symptoms in Alzheimer’s disease. Alzheimers Dement. 2011;7:532–9.CrossRefPubMedPubMedCentral
3.
4.
Fairbairn A, Gould N, Kendall TD. Supporting people with dementia and their carers in health and social care. Manchester: National Institute for Health and Care Excellence; 2006. clinical guideline 42.
5.
Scherder EJA, Bogen T, Eggermont LHP, Hamers JPH, Swaab DF. The more physical inactivity, the more agitation in dementia. Int Psychogeriatr. 2010;22:1203–8.CrossRefPubMed
6.
Christofoletti G, Oliani MM, Bucken-Gobbi LT, Gobbi S, Beinotti F, Stella F. Physical activity attenuates neuropsychiatric disturbances and caregiver burden in patients with dementia. Clinics. 2011;66:613–8.CrossRefPubMedPubMedCentral
7.
Gauthier CJ, Lefort M, Mekary S, Desjardins-Crépeau L, Skimminge A, Iversen P, et al. Hearts and minds: linking vascular rigidity and aerobic fitness with cognitive aging. Neurobiol Aging. 2014;36:304–14.CrossRefPubMed
8.
Lange-Asschenfeldt C, Kojda G. Alzheimer’s disease, cerebrovascular dysfunction and the benefits of exercise: from vessels to neurons. Exp Gerontol. 2008;43:499–504.CrossRefPubMed
9.
Newson RS, Kemps EB. Cardiorespiratory fitness as a predictor of successful cognitive ageing. J Clin Exp Neuropsychol. 2006;28:949–67.CrossRefPubMed
10.
Lautenschlager NT. Physical activity in Alzheimer’s disease: research in its infancy or why we need more randomized controlled trials. Int Psychogeriatr. 2014;26:7.PubMed
11.
12.
Burge E, Kuhne N, Berchtold A, Maupetit C, Gunten A. Impact of physical activity on activity of daily living in moderate to severe dementia: a critical review. Eur Rev Aging Phys Act. 2012;9:27–39.CrossRefPubMed
13.
Thuné-Boyle ICV, Iliffe S, Cerga-Pashoja A, Lowery D, Warner J. The effect of exercise on behavioral and psychological symptoms of dementia: towards a research agenda. Int Psychogeriatr. 2012;24:1046–57.CrossRefPubMed
14.
Rolland Y, Pillard F, Klapouszczak A, Reynish E, Thomas DR, Andrieu S, et al. Exercise program for nursing home residents with Alzheimer’s disease: a 1-year randomized, controlled trial. J Am Geriatr Soc. 2007;55:158–65.CrossRefPubMed
15.
Cohen-Mansfield J, Thein K, Dakheel-Ali M, Marx MS. Engaging nursing home residents with dementia in activities: the effects of modeling, presentation order, time of day, and setting characteristics. Aging Ment Health. 2010;14:471–80.CrossRefPubMedPubMedCentral
16.
Coogan AN, Schutová B, Husung S, Furczyk K, Baune BT, Kropp P, et al. the circadian system in alzheimer’s disease: disturbances, mechanisms, and opportunities. Biol Psychiatry. 2013;74:333–9.CrossRefPubMed
17.
Van Someren EJW, Hagebeuk EE, Lijzenga C, Scheltens P, Rooij SED, Jonker C, et al. Circadian rest-activity rhythm disturbances in Alzheimer’s disease. Biol Psychiatry. 1996;40:259–70.CrossRefPubMed
18.
Atkinson G, Edwards B, Reilly T, Waterhouse J. Exercise as a synchroniser of human circadian rhythms: an update and discussion of the methodological problems. Eur J Appl Physiol. 2007;99:331–41.CrossRefPubMed
19.
20.
Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113:941–8.CrossRefPubMed
21.
Hestermann U, Backenstrass M, Gekle I, Hack M, Mundt C, Oster P, et al. Validation of a German version of the confusion assessment method for delirium detection in a sample of acute geriatric patients with a high prevalence of dementia. Psychopat. 2009;42:270–6.CrossRef
22.
Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142–8.CrossRefPubMed
23.
Faul F, Erdfelder E, Lang A, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–91.CrossRefPubMed
24.
Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, et al. Validity and reliability of the Alzheimer’s disease cooperative study-clinical global impression of change. Alzheimer Dis Assoc Disord. 1997;2(11 Suppl):S22–32.CrossRef
25.
Drye LT, Ismail Z, Porsteinsson AP, Rosenberg PB, Weintraub D, Marano C, et al. Citalopram for agitation in Alzheimer’s disease: design and methods. Alzheimers Dement. 2012;8:121–30.CrossRefPubMedPubMedCentral
26.
Cohen J. Statistical power analysis for the behavioral sciences. New York, N.Y: Psychology Pres; 1988.
27.
Saghaei M. Implementation of an open-source customizable minimization program for allocation of patients to parallel groups in clinical trials. J Biomed Sci Eng. 2011;4:734–9.CrossRef
28.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.CrossRefPubMed
29.
Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H. The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord. 1998;9(Suppl) 2:20–6.CrossRef
30.
Sunderland T, Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA, et al. Clock drawing in Alzheimer’s disease. A novel measure of dementia severity. J Am Geriatr Soc. 1989;37:725–9.CrossRefPubMed
31.
Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002;8:448–60.CrossRefPubMed
32.
Ries JD, Echternach LN, Gagon BM. Test-retest reliability and minimal detectable change scores for the timed “up & go” test, the six-minute walk test, and gait speed in people with Alzheimer disease. Phys Ther. 2009;89:569–79.CrossRefPubMed
33.
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308–14.CrossRefPubMed
34.
Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. J Gerontol. 1989;44:M77–84.CrossRefPubMed
35.
Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho B. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry. 2010;67:255–62.CrossRefPubMed
36.
Holzbach R, Martens MS, Kalke J, Raschke P. Zusammenhang zwischen Verschreibungsverhalten der Arzte und Medikamentenabhängigkeit ihrer Patienten. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010;53:319–25.CrossRefPubMed
37.
Bezchlibnyk-Butler KZ, Jeffries JJ, Virani AS. Clinical handbook of psychotropic drugs. 18th ed. Ashland, Ohio, London: Hogrefe & Huber; Momenta [distributor]; 2009.
38.
Trost SG, Mc Iver KL, Pate RR. Conducting accelerometer-based activity assessments in field-based research. Med Sci Sports Exerc. 2005;37:S531.CrossRefPubMed
39.
Hatfield CF, Herbert J, van Someren EJW, Hodges JR, Hastings MH. Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer’s dementia. Brain. 2004;127:1061–74.CrossRefPubMed
40.
41.
Laske C, Stransky E, Leyhe T, Eschweiler GW, Wittorf A, Richartz E, et al. Stage-dependent BDNF serum concentrations in Alzheimer’s disease. J Neural Transm. 2006;113:1217–24.CrossRefPubMed
42.
Coelho FGM, Gobbi S, Andreatto CAA, Corazza DI, Pedroso RV, Santos-Galduróz RF. Physical exercise modulates peripheral levels of brain-derived neurotrophic factor (BDNF): A systematic review of experimental studies in the elderly. Arch Gerontol Geriatr. 2013;56:10–5.CrossRefPubMed
43.
44.
Edwards N, Gardiner M, Ritchie DM, Baldwin K, Sands L. Effect of exercise on negative affect in residents in special care units with moderate to severe Dementia. Alzheimer Dis Assoc Disord. 2008;22:362–8.CrossRefPubMed
45.
Witting W, Kwa IH, Eikelenboom P, Mirmiran M, Swaab DF. Alterations in the circadian rest-activity rhythm in aging and Alzheimer’s disease. Biol Psychiatry. 1990;27:563–72.CrossRefPubMed
46.
Kirste T, Hoffmeyer A, Koldrack P, Bauer A, Schubert S, Schröder S, et al. Detecting the effect of Alzheimer’s disease on everyday motion behavior. J Alzheimers Dis. 2013;38:121–32.
47.
Mulsant BH. Challenges of the treatment of neuropsychiatric symptoms associated with dementia. Am J Geriatr Psychiatr. 2014;22:317–20.CrossRef
48.
Raskind MA, Wang LY. Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action. Int Psychogeriatr. 2014;26:879–83.CrossRefPubMed
49.
Rimmer J, Smith D. Alzheimer’s Disease. In: Durstine L, Moore G, Painter P, Roberts S, editors. ACSM’s exercise management for persons with chronic diseases and disabilities. 3rd ed. Champaign, IL: Human Kinetics; 2009. p. 368–74.
50.
Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin. Demenz: Leitlinie Langfassung. 2008th edition. Düsseldorf: Omikron Publ; 2008.
51.
Staedt J, Stoppe G. Treatment of rest-activity disorders in dementia and special focus on sundowning. Int J Geriatr Psychiatry. 2005;20:507–11.CrossRefPubMed
52.
Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, et al. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep. 2007;30:519–29.PubMed
53.
Bankole A, Anderson M, Smith-Jackson T, Knight A, Oh K, Brantley J, et al. Validation of noninvasive body sensor network technology in the detection of agitation in dementia. Am J Alzheimers Dis Other Demen. 2012;27:346–54.CrossRefPubMed
54.
Borg G. Percieved exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;2:92–8.PubMed
55.
Metadata
Title
Evaluation of a hospital-based day-structuring exercise programme on exacerbated behavioural and psychological symptoms in dementia - the exercise carrousel: study protocol for a randomised controlled trial
Authors
Tim Fleiner
Wiebren Zijlstra
Hannah Dauth
Peter Haussermann
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Trials / Issue 1/2015
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-015-0758-2

Other articles of this Issue 1/2015

Trials 1/2015 Go to the issue

Study protocol

Effect of a high-dose target-controlled naloxone infusion on pain and hyperalgesia in patients following groin hernia repair: study protocol for a randomized controlled trial

Study protocol

Home-based tele-supervising rehabilitation for brain infarction patients (HTRBIP): study protocol for a randomized controlled trial

Study protocol

Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial

Study protocol

Rationale and study design for an individualized perioperative open lung ventilatory strategy (iPROVE): study protocol for a randomized controlled trial

Study protocol

Oropharyngeal administration of mother’s colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial

Study protocol

The effects of an Audio Visual Assisted Therapy Aid for Refractory auditory hallucinations (AVATAR therapy): study protocol for a randomised controlled trial